Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
NCT05310916
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Retinopathy
Interventions
DRUG:
Dapagliflozin 10mg Tab plus another oral hypoglycemic agent
DRUG:
Two oral hypoglycemic agents other than dapagliflozin
Sponsor
Nidae Alaa